PharmaBridge: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PharmaBridge
Largest movements
- Tangible fixed assets -€43,997
down €43,997 (-14.2%), from €310,768 to €266,772
of which Land and buildings: -€34,605
- Cash +€39,429
up €39,429 (+11.7%), from €335,720 to €375,149
mainly Investment in fixed assets (net) (+€32,631) and Depreciation (+€12,751)
- Receivables within one year -€7,455
down €7,455 (-17.0%), from €43,895 to €36,439
of which Trade receivables: -€19,244
- Reserves -€7,579
down €7,579 (-0.9%), from €819,225 to €811,647
of which Tax-exempt reserves: -€18,750
- Gross operating margin -€40,250
down €40,250 (-72.7%), from €55,392 to €15,141
- Depreciation -€15,827
down €15,827 (-55.4%), from €28,577 to €12,751
- Other operating charges -€1,495
down €1,495 (-28.3%), from €5,279 to €3,784
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €691,767 | €684,266 | -€7,502 | -1.1% |
| Fixed assets | 21/28 | €312,153 | €266,772 | -€45,381 | -14.5% |
| Tangible fixed assets | 22/27 | €310,768 | €266,772 | -€43,997 | -14.2% |
| Land and buildings | 22 | €269,169 | €234,564 | -€34,605 | -12.9% |
| Plant, machinery and equipment | 23 | €2,618 | €1,801 | -€817 | -31.2% |
| Furniture and vehicles | 24 | €33,981 | €25,406 | -€8,574 | -25.2% |
| Other tangible fixed assets | 26 | €5,000 | €5,000 | = | 0.0% |
| Financial fixed assets | 28 | €1,385 | €0 | -€1,385 | -100.0% |
| Current assets | 29/58 | €379,614 | €417,494 | +€37,880 | +10.0% |
| Amounts receivable within one year | 40/41 | €43,895 | €36,439 | -€7,455 | -17.0% |
| Trade receivables | 40 | €23,418 | €4,174 | -€19,244 | -82.2% |
| Other amounts receivable | 41 | €20,477 | €32,266 | +€11,789 | +57.6% |
| Cash at bank and in hand | 54/58 | €335,720 | €375,149 | +€39,429 | +11.7% |
| Deferred charges and accrued income | 490/1 | - | €5,906 | +€5,906 | |
| Total equity and liabilities | 10/49 | €691,767 | €684,266 | -€7,502 | -1.1% |
| Equity | 10/15 | €687,411 | €679,832 | -€7,579 | -1.1% |
| Contributions | 10/11 | €20,000 | €20,000 | = | 0.0% |
| Reserves | 13 | €819,225 | €811,647 | -€7,579 | -0.9% |
| Non-distributable reserves | 130/1 | €0 | - | = | |
| Reserves not available under the articles | 1311 | €0 | - | = | |
| Tax-exempt reserves | 132 | €18,750 | €0 | -€18,750 | -100.0% |
| Distributable reserves | 133 | €800,475 | €811,647 | +€11,171 | +1.4% |
| Profit (loss) carried forward | 14 | -€151,815 | -€151,815 | = | 0.0% |
| Amounts payable | 17/49 | €4,357 | €4,434 | +€77 | +1.8% |
| Amounts payable within one year | 42/48 | €3,227 | €3,234 | +€7 | +0.2% |
| Trade debts | 44 | €1,402 | €1,154 | -€248 | -17.7% |
| Suppliers | 440/4 | €1,402 | €1,154 | -€248 | -17.7% |
| Taxes, remuneration and social security | 45 | - | €2,080 | +€2,080 | |
| Taxes | 450/3 | - | €2,080 | +€2,080 | |
| Other amounts payable | 47/48 | €1,825 | €0 | -€1,825 | -100.0% |
| Accrued charges and deferred income | 492/3 | €1,130 | €1,200 | +€70 | +6.2% |
| Non-recurring operating income | 76A | €0 | €17,494 | +€17,494 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €28,577 | €12,751 | -€15,827 | -55.4% |
| Other operating charges | 640/8 | €5,279 | €3,784 | -€1,495 | -28.3% |
| Gross operating margin | 9900 | €55,392 | €15,141 | -€40,250 | -72.7% |
| Operating profit (loss) | 9901 | €21,535 | -€1,393 | -€22,929 | |
| Financial income | 75/76B | €1,407 | €1,601 | +€194 | +13.8% |
| Recurring financial income | 75 | €1,407 | €1,601 | +€194 | +13.8% |
| Financial charges | 65/66B | €194 | €315 | +€121 | +62.3% |
| Recurring financial charges | 65 | €194 | €315 | +€121 | +62.3% |
| Profit (loss) for the period before taxes | 9903 | €22,748 | -€107 | -€22,855 | |
| Income taxes | 67/77 | €7,027 | €7,471 | +€444 | +6.3% |
| Profit (loss) for the period | 9904 | €15,721 | -€7,579 | -€23,300 | |
| Transfer from tax-exempt reserves | 789 | - | €18,750 | +€18,750 | |
| Profit (loss) for the period to be appropriated | 9905 | €15,721 | €11,171 | -€4,550 | -28.9% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 6 October 2026 via checked.be.